國家衛生研究院 NHRI:Item 3990099045/9851
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 915230      Online Users : 1356
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/9851


    Title: Identification of kininogen-1 as a potential prognostizc biomarker for oral cancer
    Authors: Yen, CY;Jiang, SS;Hsiao, JR;Chen, CH;Liu, KJ
    Contributors: National Institute of Cancer Research
    Abstract: Background: Oral cancer is a serious health-care problem in several Asian countries.Methods: We used a carcinogen-induced mouse cancer model and mass spectrometry to identify potential biomarkers for the diagnosis or treatment of oral cancer. Two chemicals, 4-nitroquinoline 1-oxide (4-NQO) and arecoline (an extract of areca nut), in drinking water were used to induce oral squamous cell carcinoma in mice. Mass spectrometry analysis of sera sequentially collected from these mice showed that the level of several glycoproteins—including kininogen-1, thrombospondin-1, and leukaemia inhibitory factor receptor—was significantly elevated during early pathological changes of the tongue. Immunohistochemical staining showed kininogen-1 in the tumours of nine of 10 patients with oral cancer. We further collected tissue sections from 44 patients with T1/T2/N0 tumours, 35 patients with T1/T2/N+ tumours, 33 patients with T3/T4/N0 tumours, and 32 patients with T3/T4/N+ tumours, and determined the expression of kininogen-1 in the tumours by immunohistochemistry.Findings: Kininogen-1 is expressed in almost all tumours, and the percentage of tumour stained positive for kininogen-1 significantly increased from T1 to T2 stages. Increased kininogen-1 expression was seen in primary tumors of patients with large tumour and lymph node metastasis. Microarray analysis of gene expression between 40 pairs of human oral cancer specimens and adjacent normal specimens obtained from a different group of patients showed that the expression of kininogen-1 mRNA is substantially elevated in the tumours. mRNA expression of kininogen-1 and survival data from the 40 patients reveal that patients with tumours expressing a high level of kininogen-1 tend to have a shorter overall survival (Cox regression model analysis, p = 0.00051) and recurrence-free survival (p = 0.000575).Interpretation: Kininogen-1 could be a surrogate prognostic biomarker for patients with oral cancer.
    Date: 2016-06
    Relation: European Journal of Cancer. 2016 Jun;603-615(Suppl. 1):e10.
    Link to: http://dx.doi.org/10.1016/j.ejca.2016.03.039
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0959-8049&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000431641200027
    Appears in Collections:[Ko-Jiunn Liu] Conference Papers/Meeting Abstract
    [Shih-Sheng Jiang] Conference Papers/Meeting Abstract

    Files in This Item:

    File Description SizeFormat
    SDO0959804916320019.pdf38KbAdobe PDF472View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback